share_log

华海药业(600521.SH):产品拟中选第十批全国药品集中采购

Zhejiang Huahai Pharmaceutical (600521.SH): Products are expected to be selected for the tenth batch of national pharmaceutical centralized procurement.

Gelonghui Finance ·  Dec 13 15:48

Gelonghui, December 13, 丨 Huahai Pharmaceutical (600521.SH) announced that on December 12, 2024, the company participated in the bidding process for the 10th batch of centralized national drug procurement organized by the State Drug Joint Procurement Office (“Joint Procurement Office”). The company's products rasagiline mesylate tablets and sitagliptin metformin tablets (II) will be selected for this centralized procurement.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment